Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy.

Autor: Salehi Omran H; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Irilouzadian R; Burn Research Center, Iran University of Medical Sciences, Tehran, Iran., Hedayati Goudarzi MT; Department of Cardiology, Rohani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran., Salehi Omran MT; Department of Cardiology, Babol University of Medical Sciences, Babol, Iran.
Jazyk: angličtina
Zdroj: Clinical cardiology [Clin Cardiol] 2023 Oct; Vol. 46 (10), pp. 1297-1298. Date of Electronic Publication: 2023 Aug 22.
DOI: 10.1002/clc.24138
Abstrakt: Our previous study aimed to investigate overall survival (OS) and sudden cardiac death (SCD) variables in nonischemic dilated cardiomyopathy (DCM) patients treated only with standard medical treatments versus those who received implantable cardioverter defibrillator (ICD) in addition to routine medical treatments. Our findings revealed no significant difference in OS between the two groups (p = .25), but a significant decrease in SCD rate due to ICD insertion (p = .02). Furthermore, we found no significant difference between the two groups concerning baseline characteristics and type of medical treatments received. We attempted to answer and clarify the concerning points regarding the survival benefits of ICD insertion in nonischemic DCM patients that were mentioned.
(© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: